Literature DB >> 24419111

Phase I trial improvement: a question of patient selection, trial design, or both?

Karla V Ballman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24419111     DOI： 10.1200/JCO.2013.53.6896

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Mitochondrial Replacement Therapy: Halachic Considerations for Enrolling in an Experimental Clinical Trial.

Authors:  Rabbi Moshe D Tendler; John D Loike
Journal:  Rambam Maimonides Med J       Date:  2015-07-30

2.  Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials.

Authors:  Joeri A J Douma; Sonja Zweegman; Mieke Alberts; Sandy Kruyswijk; Niels C W J van de Donk; Myra van Linde; Laurien M Buffart; Henk M W Verheul
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.359
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.